Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ORGS |
---|---|---|
09:34 ET | 1000 | 0.84 |
09:38 ET | 4352 | 0.84 |
10:03 ET | 200 | 0.8499 |
01:17 ET | 300 | 0.84 |
01:48 ET | 500 | 0.844949 |
01:50 ET | 564 | 0.8498 |
02:08 ET | 300 | 0.83 |
02:18 ET | 947 | 0.8216 |
02:36 ET | 100 | 0.8216 |
03:07 ET | 100 | 0.849899 |
03:12 ET | 996 | 0.822 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Orgenesis Inc | 27.4M | -0.9x | --- |
SANUWAVE Health Inc | 24.6M | -0.5x | --- |
Dalrada Financial Corp | 13.6M | -0.6x | --- |
Precision Optics Corporation Inc | 33.7M | -19.2x | --- |
DarioHealth Corp | 41.6M | -0.7x | --- |
DermTech Inc | 24.3M | -0.2x | --- |
Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Company’s therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomera’s services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $27.4M |
---|---|
Revenue (TTM) | $27.8M |
Shares Outstanding | 33.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.07 |
EPS | $-0.90 |
Book Value | $1.08 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 1.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -67.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.